Donna R. Rivera

Economics, Econometrics and FinanceMedicineBiochemistry, Genetics and Molecular BiologyMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.7Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Knowledge Graph-Enabled Cancer Data Analytics

IEEE Journal of Biomedical and Health Informatics(2020)10.1109/jbhi.2020.2990797

Top 9%

2.3DataRank

Top 9%50 citations

Donna R. Rivera, Xiao‐Cheng Wu, Eric B. Durbin, J. Blair Christian, Georgia D. Tourassi +1 more

Papers

Driven by 34 papers — median percentile 53. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Knowledge Graph-Enabled Cancer Data Analytics

IEEE Journal of Biomedical and Health Informatics(2020)10.1109/jbhi.2020.2990797

Top 9%

2.3DataRank

Top 9%50 citations

Donna R. Rivera, Xiao‐Cheng Wu, Eric B. Durbin, J. Blair Christian, Georgia D. Tourassi +1 more

FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1270

N/A

1.2DataRank · unranked

46 citations

Diana Bradford, Xiaoxue Li, Pallavi S. Mishra‐Kalyani, Yuan Li Shen, Lingshan Wang +14 more

US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy

Journal of Clinical Oncology(2024)10.1200/jco.24.00546

N/A

0.584DataRank · unranked

15 citations

Diana Bradford, A. K. Sinha, Pallavi S. Mishra‐Kalyani, Catherine C. Lerro, Donna R. Rivera +13 more

Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0266

Top 34%

0.576DataRank

Top 34%10 citations

Andrea Pistillo, Martina Recalde, Anthony G. Sena, Sergio Fernández‐Bertolín, María Aragón +48 more

Utilization of the Cancer Medications Enquiry Database (CanMED)-National Drug Codes (NDC): Assessment of Systemic Breast Cancer Treatment Patterns

JNCI Monographs(2020)10.1093/jncimonographs/lgaa002

Top 36%

0.535DataRank

Top 36%10 citations

Andrew Grothen, Bradley Ohm, Timothy S. McNeel, Sean Brennan, Clara Lam +4 more

The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07433-4

N/A

0.359DataRank · unranked

7 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +18 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4429

N/A

0DataRank · unranked

4 citations

Yutao Gong, Kirsten B. Goldberg, Paul G. Kluetz, Marc R. Theoret, Laleh Amiri‐Kordestani +13 more

Characteristics and outcomes of 118,155 COVID-19 individuals with a history of cancer in the United States and Spain

medRxiv(2021)10.1101/2021.01.12.21249672

Top 100%

0DataRank

Top 100%0 citations

Andrea Pistillo, Martina Recalde, Anthony G. Sena, Sergio Fernández‐Bertolín, María Aragón +48 more

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

The Lancet Healthy Longevity(2022)10.1016/s2666-7568(22)00009-5

N/A

0DataRank · unranked

22 citations

Cassandra Hennessy, Nicole M. Kuderer, Samuel M. Rubinstein, Elizabeth Wulff‐Burchfield, Rachel Rosovsky +45 more

Development of a bayesian toxo-equivalence model between docetaxel and paclitaxel

iScience(2022)10.1016/j.isci.2022.104045

N/A

0DataRank · unranked

2 citations

Samuel M. Rubinstein, Sandip Chaugai, Donna R. Rivera, Philip Walker, Qingxia Chen +2 more

Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0125

N/A

0DataRank · unranked

35 citations

Daniel C. Beachler, Ruth M. Pfeiffer, Jeffrey R. Curtis, Xavier Mariette, Raphaèle Séror +5 more

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2023.100445

N/A

0DataRank · unranked

39 citations

Chris Labaki, Ziad Bakouny, Chih–Yuan Hsu, Andrew Schmidt, Gilberto Lopes +39 more

Trends in new and persistent opioid use in older adults with and without cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad206

N/A

0DataRank · unranked

11 citations

Madhav KC, Pamela R. Soulos, Molly M. Jeffery, Kathryn J. Ruddy, Catherine C. Lerro +9 more

FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1133

N/A

0DataRank · unranked

9 citations

Christy Osgood, Zhou Feng, Erik Bloomquist, Shenghui Tang, C.J. George Chang +8 more

Trends in FDA cancer registration trial design over time, 1969-2020.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2060

N/A

0DataRank · unranked

7 citations

Tarsheen Sethi, Donna R. Rivera, Neeta K. Venepalli, Travis Osterman, Ali Raza Khaki +2 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

The evolving landscape of chemotherapy for the treatment of early-stage breast cancer from 2006-2019: Results of a retrospective cohort study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6600

N/A

0DataRank · unranked

0 citations

Kelli O’Connell, Rachael Burganowski, Isaac J. Ergas, Grace B Gallagher, Jennifer J. Griggs +15 more

Provider- and facility-level factors in relation to patients’ receipt of chemotherapy, time to chemotherapy initiation, and receipt of guideline regimens: Results from the optimal breast cancer chemotherapy dosing study.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.540

N/A

0DataRank · unranked

0 citations

Kelli O’Connell, Jenna Bhimani, Isaac J. Ergas, Narre Heon, Grace B Gallagher +15 more

COVID-19 Usurps Host Regulatory Networks

Frontiers in Pharmacology(2020)10.3389/fphar.2020.01278

N/A

0DataRank · unranked

31 citations

Donna R. Rivera, Jeffrey B. Kopp, Colleen S. Curran

Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019

Breast Cancer Research(2024)10.1186/s13058-024-01822-9

N/A

0DataRank · unranked

11 citations

Kelli O’Connell, Isaac J. Ergas, Marilyn J. Foley, Grace Gallagher, Jennifer J. Griggs +17 more

Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials

Cancer(2024)10.1002/cncr.35528

N/A

0DataRank · unranked

10 citations

Nancy Campbell, Shauna L. Hillman, Elizabeth S. Harlos, David Stein, Miranda Y. Chan +14 more

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0941

N/A

0DataRank · unranked

138 citations

Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih–Yuan Hsu +40 more

Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–IIIA breast cancer

International Journal of Cancer(2024)10.1002/ijc.35053

N/A

0DataRank · unranked

4 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +19 more

Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0360

N/A

0DataRank · unranked

2 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael P. Burganowski-Doud, Isaac J. Ergas +18 more

Provider and facility factors in relation to receipt of dose-reduced chemotherapy among patients with breast cancer.

JCO Oncology Practice(2024)10.1200/op.2024.20.10_suppl.310

N/A

0DataRank · unranked

0 citations

Kelli O’Connell, Jenna Bhimani, Victoria Blinder, Rachael Doud, Grace Gallagher +15 more

A Unified Approach to Health Data Exchange

JAMA(2025)10.1001/jama.2025.0068

N/A

0DataRank · unranked

26 citations

Jennifer E. Layden, William Gordon, Susan Gregurick, Nancy DeLew, Jordan Grossman +22 more

Opportunities for Pragmatic Design Elements in Surgical Trials

JAMA Surgery(2025)10.1001/jamasurg.2025.3041

N/A

0DataRank · unranked

9 citations

Adam S. Weltz, Donna R. Rivera, Steven Nagel, Gautam U. Mehta, Binita S. Ashar +2 more

Real‐World Evidence in New Drug and Biologics License Application Approvals During Fiscal Years 2020–2022

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3688

N/A

0DataRank · unranked

6 citations

Kimberly Smith, Aida Kuzucan, Jie Li, Donna R. Rivera, Orestis A. Panagiotou +2 more

FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0688

N/A

0DataRank · unranked

3 citations

Donna R. Rivera, Joseph Wynne, Jian Zhao, Robyn Konicki, Aida Kuzucan +8 more

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf314

N/A

0DataRank · unranked

1 citations

Kelli O’Connell, Jenna Bhimani, Grace Gallagher, Victoria Blinder, Rachael Doud +19 more

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

UNC Libraries(2025)10.17615/bna9-v350

N/A

0DataRank · unranked

0 citations

Sanjay Mishra, Karen Russell, Samuel M. Rubinstein, Blau, Sibel, Daniel Y. Reuben +39 more

Donna R. Rivera

Indexed papers

Top data-sharing exemplar

Papers